Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Sentinel lymph node mapping in breast cancer.

¹The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York 10021, USA.

Breast Cancer (Tokyo, Japan)

|October 9, 2008

Summary

Sentinel lymph node (SLN) biopsy accurately identifies breast cancer spread, potentially avoiding full axillary dissection for node-negative patients. This minimally invasive procedure offers high reliability and reduced morbidity compared to traditional methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Role of sentinel node biopsy in patients having neoadjuvant chemotherapy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2010

Same author

The role of sentinel lymph node biopsy in Paget's disease of the breast.

Annals of surgical oncology·2007

Same author

Pleomorphic adenoma of the breast: case report and review of the literature.

Diagnostic cytopathology·2005

Same author

A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2002

Same author

Surgical approach to internal mammary lymph node biopsy.

Journal of the American College of Surgeons·2002

Same author

A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer.

Journal of the American College of Surgeons·2001

Area of Science:

Oncology
Surgical Oncology
Breast Cancer Research

Background:

Sentinel lymph node (SLN) biopsy is a key procedure for early-stage invasive breast cancer with a clinically negative axilla.
Mammographic detection increases the number of node-negative breast cancer patients who may benefit from avoiding axillary dissection.

Purpose of the Study:

To evaluate the efficacy and accuracy of sentinel lymph node biopsy in predicting axillary lymph node status for breast cancer patients.
To highlight the potential of SLN biopsy to reduce morbidity associated with conventional axillary dissection.

Main Methods:

Localization of SLNs using radioisotope, blue dye, or a combination of both.
Validation of SLN identification success rates, typically exceeding 90% with experience.

More Related Videos

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Related Experiment Videos

Last Updated: Jun 29, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Utilizing enhanced pathologic analysis, including serial sectioning and immunohistochemistry, for accurate staging.

Main Results:

SLN biopsy reliably predicts axillary node status in 98% of all patients and 95% of node-positive patients.
Successful SLN localization rates are high, exceeding 90% with experienced practitioners.
The procedure demonstrates lower morbidity and greater accuracy compared to conventional axillary dissection when performed by experienced surgeons.

Conclusions:

Sentinel lymph node biopsy is an accurate and reliable method for staging the axilla in early breast cancer.
The technique offers a less morbid alternative to axillary dissection for select patients, particularly in the era of early cancer detection.
Formalized training protocols and enhanced pathologic analysis are crucial for successful implementation and optimal patient outcomes.